Literature DB >> 21281684

No need for a large belly to have NASH.

Mariana Verdelho Machado, Helena Cortez-Pinto.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21281684     DOI： 10.1016/j.jhep.2011.01.010

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  10 in total

Review 1.  Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index.

Authors:  Qing Pang; Jing-Yao Zhang; Si-Dong Song; Kai Qu; Xin-Sen Xu; Su-Shun Liu; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

2.  Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression.

Authors:  J Barr; J Caballería; I Martínez-Arranz; A Domínguez-Díez; C Alonso; J Muntané; M Pérez-Cormenzana; C García-Monzón; R Mayo; A Martín-Duce; M Romero-Gómez; O Lo Iacono; J Tordjman; R J Andrade; M Pérez-Carreras; Y Le Marchand-Brustel; A Tran; C Fernández-Escalante; E Arévalo; M García-Unzueta; K Clement; J Crespo; P Gual; M Gómez-Fleitas; M L Martínez-Chantar; A Castro; S C Lu; M Vázquez-Chantada; J M Mato
Journal:  J Proteome Res       Date:  2012-03-15       Impact factor: 4.466

Review 3.  Recent advances in the development of farnesoid X receptor agonists.

Authors:  Ahmad H Ali; Elizabeth J Carey; Keith D Lindor
Journal:  Ann Transl Med       Date:  2015-01

4.  Fatty liver in lean patients: is it a different disease?

Authors:  Mariana Verdelho Machado; Helena Cortez-Pinto
Journal:  Ann Gastroenterol       Date:  2012

Review 5.  Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications.

Authors:  Ramesh Kumar; Shantam Mohan
Journal:  J Clin Transl Hepatol       Date:  2017-07-05

Review 6.  Current and Future Treatments in the Fight Against Non-Alcoholic Fatty Liver Disease.

Authors:  Benoit Smeuninx; Ebru Boslem; Mark A Febbraio
Journal:  Cancers (Basel)       Date:  2020-06-28       Impact factor: 6.639

7.  Assessment of the relationship of serum liver enzymes activity with general and abdominal obesity in an urban Bangladeshi population.

Authors:  Nurshad Ali; Abu Hasan Sumon; Khandaker Atkia Fariha; Md Asaduzzaman; Rahanuma Raihanu Kathak; Noyan Hossain Molla; Ananya Dutta Mou; Zitu Barman; Mahmudul Hasan; Rakib Miah; Farjana Islam
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

Review 8.  The Gut-Liver Axis in Chronic Liver Disease: A Macrophage Perspective.

Authors:  Kevin De Muynck; Bart Vanderborght; Hans Van Vlierberghe; Lindsey Devisscher
Journal:  Cells       Date:  2021-10-30       Impact factor: 6.600

9.  Oral Nitrate Reductase Activity Is Not Associated with Development of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Pilot Study.

Authors:  Gilda Barzin; Shahin Merat; Habibeh Nokhbeh-Zaeem; Parastoo Saniee; Shahrzad Pedramnia; Ali Mostashfi Habibabadi; Siavosh Nasseri-Moghaddam
Journal:  Middle East J Dig Dis       Date:  2014-01

Review 10.  Metabolic drivers of non-alcoholic fatty liver disease.

Authors:  Kendra K Bence; Morris J Birnbaum
Journal:  Mol Metab       Date:  2020-12-17       Impact factor: 7.422
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.